E. Karge

605 total citations
43 papers, 491 citations indexed

About

E. Karge is a scholar working on Pharmacology, Molecular Biology and Oncology. According to data from OpenAlex, E. Karge has authored 43 papers receiving a total of 491 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pharmacology, 10 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in E. Karge's work include Pharmacogenetics and Drug Metabolism (15 papers), Drug Transport and Resistance Mechanisms (8 papers) and Drug-Induced Hepatotoxicity and Protection (5 papers). E. Karge is often cited by papers focused on Pharmacogenetics and Drug Metabolism (15 papers), Drug Transport and Resistance Mechanisms (8 papers) and Drug-Induced Hepatotoxicity and Protection (5 papers). E. Karge collaborates with scholars based in Germany, Czechia and France. E. Karge's co-authors include Christian Fleck, Frank Schweitzer, Günter Stein, W Klinger, Alexander Janz, Markus Schwertfeger, Martin Busch, Amelie Lupp, R Glöckner and M. Rost and has published in prestigious journals such as Kidney International, Biochemical Pharmacology and Clinica Chimica Acta.

In The Last Decade

E. Karge

41 papers receiving 473 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Karge Germany 12 181 128 81 69 52 43 491
Chiara Bencini Italy 13 102 0.6× 94 0.7× 157 1.9× 93 1.3× 16 0.3× 23 581
Jacek Spławiński Poland 16 122 0.7× 109 0.9× 195 2.4× 66 1.0× 44 0.8× 45 718
Priska Kaufmann Switzerland 13 94 0.5× 151 1.2× 307 3.8× 114 1.7× 73 1.4× 36 777
İlker Kanzık Türkiye 16 210 1.2× 130 1.0× 169 2.1× 38 0.6× 10 0.2× 46 798
Vladimíra Mužáková Czechia 12 107 0.6× 57 0.4× 138 1.7× 64 0.9× 57 1.1× 24 552
Malek Kechrid United States 5 61 0.3× 76 0.6× 232 2.9× 30 0.4× 81 1.6× 9 712
Mohammad Newaz United States 14 164 0.9× 94 0.7× 203 2.5× 29 0.4× 64 1.2× 34 554
Hong-Jye Hong Taiwan 12 198 1.1× 191 1.5× 269 3.3× 30 0.4× 22 0.4× 20 614
Toshihiro Matsuzaki Japan 14 233 1.3× 147 1.1× 125 1.5× 27 0.4× 18 0.3× 38 576
Gustavo H. Oliveira‐Paula Brazil 20 312 1.7× 232 1.8× 184 2.3× 65 0.9× 30 0.6× 44 842

Countries citing papers authored by E. Karge

Since Specialization
Citations

This map shows the geographic impact of E. Karge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Karge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Karge more than expected).

Fields of papers citing papers by E. Karge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Karge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Karge. The network helps show where E. Karge may publish in the future.

Co-authorship network of co-authors of E. Karge

This figure shows the co-authorship network connecting the top 25 collaborators of E. Karge. A scholar is included among the top collaborators of E. Karge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Karge. E. Karge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
3.
Fleck, Christian, Frank Schweitzer, E. Karge, Martin Busch, & Günter Stein. (2003). Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in patients with chronic kidney diseases. Clinica Chimica Acta. 336(1-2). 1–12. 110 indexed citations
4.
Lupp, Amelie, et al.. (2003). Cyclosporine A and Tacrolimus: In vitro investigations on the differential interactions with the cytochrome P450 system in rat and human liver. Experimental and Toxicologic Pathology. 54(5-6). 467–473. 1 indexed citations
8.
Fleck, Ch., et al.. (2000). Ex vivo stimulation of renal tubular p -aminohippurate transport by dexamethasone and triiodothyronine in human renal cell carcinoma. Urological Research. 28(6). 383–390. 6 indexed citations
9.
Landmann, Gunther, et al.. (1999). Influence of oestrogens on formation of reactive oxygen species in liver microsomes of differently aged male Wistar rats. Experimental and Toxicologic Pathology. 51(4-5). 282–288. 8 indexed citations
10.
Klinger, W, et al.. (1999). Interaction of chlormezanone enantiomers with rat liver microsomes. European Journal of Drug Metabolism and Pharmacokinetics. 24(1). 63–68. 1 indexed citations
11.
Klinger, W, Amelie Lupp, E. Karge, et al.. (1998). Ciprofibrate — racemate and enantiomers: Effects of a four-week treatment on male inbred Fischer rats. A biochemical and morphological study. Experimental and Toxicologic Pathology. 50(4-6). 301–314. 1 indexed citations
12.
Oelschläger, Herbert, et al.. (1998). Chromatographic resolution of Ciprofibrate and interaction of the racemate and both enantiomers with rat liver microsomes in vitro. Experimental and Toxicologic Pathology. 50(4-6). 323–329. 1 indexed citations
13.
Rost, M., E. Karge, & W Klinger. (1998). What do we measure with luminol-, lucigenin- and penicillin-amplified chemiluminescence? 1. Investigations with hydrogen peroxide and sodium hypochlorite. Journal of Bioluminescence and Chemiluminescence. 13(6). 355–363. 17 indexed citations
14.
Lupp, Amelie, et al.. (1998). Investigation on possible antioxidative properties of the NMDA-receptor antagonists ketamine, memantine, and amantadine in comparison to nicanartine in vitro. Experimental and Toxicologic Pathology. 50(4-6). 501–506. 16 indexed citations
15.
Karge, E., et al.. (1996). [The study of the in vitro effect of selenium on formation of active oxygen species and lipid peroxidation in rat liver microsomes].. PubMed. 42(2). 119–24. 1 indexed citations
16.
Klinger, W, E. Karge, Michael Kretzschmar, et al.. (1996). Luminol-and lucigenin-amplified chemiluminescence with rat liver microsomes. Experimental and Toxicologic Pathology. 48(5). 447–460. 22 indexed citations
17.
Klinger, W, et al.. (1995). Nerval influences on liver cytochrome P450. Experimental and Toxicologic Pathology. 47(4). 299–303. 1 indexed citations
18.
19.
Glöckner, R & E. Karge. (1993). Postnatal development of body mass and of hepatic xenobiotics biotransformation of male rats with low body mass at birth. Experimental and Toxicologic Pathology. 45(2-3). 145–148. 2 indexed citations
20.
Barth, A., et al.. (1975). On the selectivity of aryl hydrocarbon hydroxylase induction after 3-methylcholanthrene pretreatment.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 34?710. 1701–5. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026